• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading.载有难溶性药物纳米颗粒的条带状薄膜的关键材料属性(CMAs):III. 药物纳米颗粒载药量的影响
Int J Pharm. 2017 May 15;523(1):33-41. doi: 10.1016/j.ijpharm.2017.03.023. Epub 2017 Mar 16.
2
Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution.载有难溶性药物纳米颗粒的条带薄膜的关键材料属性(CMA):I. 增塑剂对薄膜性能和溶出度的影响
Eur J Pharm Sci. 2016 Sep 20;92:146-55. doi: 10.1016/j.ejps.2016.07.005. Epub 2016 Jul 8.
3
Critical Material Attributes of Strip Films Loaded With Poorly Water-Soluble Drug Nanoparticles: II. Impact of Polymer Molecular Weight.负载难溶性药物纳米颗粒的条带状薄膜的关键材料属性:II. 聚合物分子量的影响
J Pharm Sci. 2017 Feb;106(2):619-628. doi: 10.1016/j.xphs.2016.10.009. Epub 2016 Nov 18.
4
Fast drying of biocompatible polymer films loaded with poorly water-soluble drug nano-particles via low temperature forced convection.通过低温强制对流快速干燥载有疏水性药物纳米颗粒的生物相容性聚合物薄膜。
Int J Pharm. 2013 Oct 15;455(1-2):93-103. doi: 10.1016/j.ijpharm.2013.07.051. Epub 2013 Jul 31.
5
Polymer strip films as a robust, surfactant-free platform for delivery of BCS Class II drug nanoparticles.聚合物条带薄膜作为一种用于递送BCS II类药物纳米颗粒的坚固、无表面活性剂的平台。
Int J Pharm. 2015 Jul 15;489(1-2):45-57. doi: 10.1016/j.ijpharm.2015.04.034. Epub 2015 Apr 15.
6
Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement.含BCS II类药物纳米颗粒的速溶普鲁兰多糖膜的制备及其表征,用于提高生物利用度
Drug Dev Ind Pharm. 2016;42(7):1073-85. doi: 10.3109/03639045.2015.1107094. Epub 2015 Nov 15.
7
Zero-order release of poorly water-soluble drug from polymeric films made via aqueous slurry casting.水基浆料浇铸法制备聚合物薄膜中低水溶性药物的零级释放。
Eur J Pharm Sci. 2018 May 30;117:245-254. doi: 10.1016/j.ejps.2018.02.029. Epub 2018 Feb 27.
8
Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.载药纳米粒的羟丙甲纤维素薄膜的制备与性能表征及其在药剂学中的应用
Int J Pharm. 2012 Feb 28;423(2):496-508. doi: 10.1016/j.ijpharm.2011.12.001. Epub 2011 Dec 9.
9
Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.难溶性药物的可再分散速溶纳米复合微粒
Int J Pharm. 2014 Jan 30;461(1-2):367-79. doi: 10.1016/j.ijpharm.2013.11.059. Epub 2013 Dec 11.
10
Sustained Release of Poorly Water-Soluble Drug from Hydrophilic Polymeric Film Sandwiched Between Hydrophobic Layers.疏水性层之间亲水聚合物膜中疏水性药物的持续释放。
AAPS PharmSciTech. 2018 Aug;19(6):2572-2584. doi: 10.1208/s12249-018-1089-x. Epub 2018 Jun 14.

引用本文的文献

1
Updates on the conversion of nanosuspensions to solid oral dosage forms.纳米混悬液向固体口服剂型转化的研究进展
J Food Drug Anal. 2024 Dec 15;32(4):398-411. doi: 10.38212/2224-6614.3525.
2
Development of Optimized Sumatriptan-Prochlorperazine Combined Orodispersible Films Without Disintegrant: in vitro, ex vivo and in vivo Characterization.优化的无崩解剂舒马曲坦-丙氯拉嗪复方口溶膜的研制:体外、离体和体内特性研究。
AAPS PharmSciTech. 2022 Jun 2;23(5):156. doi: 10.1208/s12249-022-02307-8.
3
Impact of Mixing on Content Uniformity of Thin Polymer Films Containing Drug Micro-Doses.混合对含药物微剂量的聚合物薄膜含量均匀性的影响。
Pharmaceutics. 2021 May 29;13(6):812. doi: 10.3390/pharmaceutics13060812.
4
Preparation of Poloxamer188--PCL and Study on Radioprotection Activity of Curcumin-Loaded Nanoparticles.泊洛沙姆188-聚己内酯的制备及载姜黄素纳米粒的辐射防护活性研究
Front Chem. 2020 Apr 15;8:212. doi: 10.3389/fchem.2020.00212. eCollection 2020.
5
Technology of Orodispersible Polymer Films with Micronized Loratadine-Influence of Different Drug Loadings on Film Properties.含微粉化氯雷他定的口腔崩解聚合物薄膜技术——不同载药量对薄膜性质的影响
Pharmaceutics. 2020 Mar 10;12(3):250. doi: 10.3390/pharmaceutics12030250.
6
Fenofibrate Nanocrystal Composite Microparticles for Intestine-Specific Oral Drug Delivery System.用于肠道特异性口服给药系统的非诺贝特纳米晶体复合微粒
Pharmaceuticals (Basel). 2019 Jul 16;12(3):109. doi: 10.3390/ph12030109.
7
Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability.难溶性药物的纳米晶体:药物生物利用度与物理化学稳定性
Pharmaceutics. 2018 Aug 21;10(3):134. doi: 10.3390/pharmaceutics10030134.
8
Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges.通过纳米复合材料提高难溶性药物的生物利用度:制剂-工艺方面及挑战
Pharmaceutics. 2018 Jul 8;10(3):86. doi: 10.3390/pharmaceutics10030086.
9
Impact of Superdisintegrants and Film Thickness on Disintegration Time of Strip Films Loaded With Poorly Water-Soluble Drug Microparticles.超崩解剂和薄膜厚度对载有难溶性药物微丸的条状薄膜崩解时间的影响。
J Pharm Sci. 2018 Aug;107(8):2107-2118. doi: 10.1016/j.xphs.2018.04.006. Epub 2018 Apr 14.
10
Zero-order release of poorly water-soluble drug from polymeric films made via aqueous slurry casting.水基浆料浇铸法制备聚合物薄膜中低水溶性药物的零级释放。
Eur J Pharm Sci. 2018 May 30;117:245-254. doi: 10.1016/j.ejps.2018.02.029. Epub 2018 Feb 27.

本文引用的文献

1
Critical Material Attributes of Strip Films Loaded With Poorly Water-Soluble Drug Nanoparticles: II. Impact of Polymer Molecular Weight.负载难溶性药物纳米颗粒的条带状薄膜的关键材料属性:II. 聚合物分子量的影响
J Pharm Sci. 2017 Feb;106(2):619-628. doi: 10.1016/j.xphs.2016.10.009. Epub 2016 Nov 18.
2
Efficient production of nanoparticle-loaded orodispersible films by process integration in a stirred media mill.通过搅拌介质磨中的工艺整合高效生产载纳米颗粒的口腔崩解膜。
Int J Pharm. 2016 Sep 25;511(2):804-13. doi: 10.1016/j.ijpharm.2016.07.058. Epub 2016 Jul 28.
3
Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution.载有难溶性药物纳米颗粒的条带薄膜的关键材料属性(CMA):I. 增塑剂对薄膜性能和溶出度的影响
Eur J Pharm Sci. 2016 Sep 20;92:146-55. doi: 10.1016/j.ejps.2016.07.005. Epub 2016 Jul 8.
4
Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement.含BCS II类药物纳米颗粒的速溶普鲁兰多糖膜的制备及其表征,用于提高生物利用度
Drug Dev Ind Pharm. 2016;42(7):1073-85. doi: 10.3109/03639045.2015.1107094. Epub 2015 Nov 15.
5
Development of orodispersible polymer films containing poorly water soluble active pharmaceutical ingredients with focus on different drug loadings and storage stability.含有低水溶性活性药物成分的口腔分散片聚合物薄膜的开发,重点在于不同的药物负载和存储稳定性。
Int J Pharm. 2015 Sep 30;493(1-2):134-45. doi: 10.1016/j.ijpharm.2015.07.032. Epub 2015 Jul 26.
6
Polymer strip films as a robust, surfactant-free platform for delivery of BCS Class II drug nanoparticles.聚合物条带薄膜作为一种用于递送BCS II类药物纳米颗粒的坚固、无表面活性剂的平台。
Int J Pharm. 2015 Jul 15;489(1-2):45-57. doi: 10.1016/j.ijpharm.2015.04.034. Epub 2015 Apr 15.
7
Oral films: Current status and future perspectives II - Intellectual property, technologies and market needs.口腔膜剂:现状与未来展望II - 知识产权、技术与市场需求
J Control Release. 2015 May 28;206:108-21. doi: 10.1016/j.jconrel.2015.03.012. Epub 2015 Mar 14.
8
Oral films: Current status and future perspectives: I - Galenical development and quality attributes.口腔膜剂:现状与未来展望 I - 制剂研发与质量属性
J Control Release. 2015 May 28;206:1-19. doi: 10.1016/j.jconrel.2015.03.006. Epub 2015 Mar 5.
9
Maltodextrin fast dissolving films for quercetin nanocrystal delivery. A feasibility study.用于槲皮素纳米晶体递送的麦芽糊精速溶薄膜。一项可行性研究。
Carbohydr Polym. 2015 May 5;121:217-23. doi: 10.1016/j.carbpol.2014.11.070. Epub 2014 Dec 31.
10
Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.个体化药学治疗中的口溶膜:药剂学制剂的一种配方开发。
Int J Pharm. 2015 Jan 15;478(1):155-163. doi: 10.1016/j.ijpharm.2014.11.013. Epub 2014 Nov 7.

载有难溶性药物纳米颗粒的条带状薄膜的关键材料属性(CMAs):III. 药物纳米颗粒载药量的影响

Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading.

作者信息

Krull Scott M, Moreno Jacqueline, Li Meng, Bilgili Ecevit, Davé Rajesh N

机构信息

Department of Chemical, Biological, and Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, NJ, United States.

Department of Chemical, Biological, and Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, NJ, United States.

出版信息

Int J Pharm. 2017 May 15;523(1):33-41. doi: 10.1016/j.ijpharm.2017.03.023. Epub 2017 Mar 16.

DOI:10.1016/j.ijpharm.2017.03.023
PMID:28315716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5488802/
Abstract

Polymer strip films have emerged as a robust platform for poorly water-soluble drug delivery. However, the common conception is that films cannot exceed low drug loadings, mainly due to poor drug stability, slow release, and film brittleness. This study explores the ability to achieve high loadings of poorly water-soluble drug nanoparticles in strip films while retaining good mechanical properties and enhanced dissolution rate. Aqueous suspensions containing up to 30wt% griseofulvin nanoparticles were prepared via wet stirred media milling and incorporated into hydroxypropyl methylcellulose (HPMC) films. Griseofulvin loading in films was adjusted to be between 9 and 49wt% in HPMC-E15 films and 30 and 73wt% in HPMC-E4M films by varying the mixing ratio of HPMC solution-to-griseofulvin suspension. All films exhibited good content uniformity and nanoparticle redispersibility up to 50wt% griseofulvin, while E4M films above 50wt% griseofulvin had slightly worse content uniformity and poor nanoparticle redispersibility. Increasing drug loading in films generally required more time to achieve 100% release during dissolution, although polymer-drug clusters dispersed from E4M films above 50wt% griseofulvin, resulting in similar dissolution profiles. While all films exhibited good tensile strength, a significant decrease in percent elongation was observed above 40-50wt% GF, resulting in brittle films.

摘要

聚合物条带薄膜已成为一种用于难溶性药物递送的强大平台。然而,普遍的观念是薄膜的药物载量不能超过低水平,这主要是由于药物稳定性差、释放缓慢以及薄膜脆性。本研究探索了在条带薄膜中实现高载量难溶性药物纳米颗粒的能力,同时保持良好的机械性能和提高溶解速率。通过湿式搅拌介质研磨制备了含高达30wt%灰黄霉素纳米颗粒的水悬浮液,并将其掺入羟丙基甲基纤维素(HPMC)薄膜中。通过改变HPMC溶液与灰黄霉素悬浮液的混合比例,将HPMC-E15薄膜中灰黄霉素的载量调整为9至49wt%,HPMC-E4M薄膜中为30至73wt%。所有薄膜在灰黄霉素载量高达50wt%时均表现出良好的含量均匀性和纳米颗粒再分散性,而灰黄霉素载量高于50wt%的E4M薄膜的含量均匀性略差且纳米颗粒再分散性不佳。增加薄膜中的药物载量通常在溶解过程中需要更多时间才能达到100%释放,尽管从灰黄霉素载量高于50wt%的E4M薄膜中分散出聚合物-药物聚集体,导致溶解曲线相似。虽然所有薄膜都表现出良好的拉伸强度,但在灰黄霉素载量高于40-50wt%时观察到伸长率百分比显著下降,导致薄膜变脆。